Sinotherapeutics Statistics
Total Valuation
SHA:688247 has a market cap or net worth of CNY 4.02 billion. The enterprise value is 3.24 billion.
| Market Cap | 4.02B |
| Enterprise Value | 3.24B |
Important Dates
The last earnings date was Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688247 has 449.00 million shares outstanding. The number of shares has decreased by -2.55% in one year.
| Current Share Class | 449.00M |
| Shares Outstanding | 449.00M |
| Shares Change (YoY) | -2.55% |
| Shares Change (QoQ) | +12.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.55% |
| Float | 102.52M |
Valuation Ratios
The trailing PE ratio is 88.92.
| PE Ratio | 88.92 |
| Forward PE | n/a |
| PS Ratio | 9.30 |
| PB Ratio | 3.07 |
| P/TBV Ratio | 3.14 |
| P/FCF Ratio | 104.17 |
| P/OCF Ratio | 57.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.71, with an EV/FCF ratio of 84.02.
| EV / Earnings | 74.41 |
| EV / Sales | 7.50 |
| EV / EBITDA | 35.71 |
| EV / EBIT | 58.43 |
| EV / FCF | 84.02 |
Financial Position
The company has a current ratio of 10.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.98 |
| Quick Ratio | 9.88 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.35% and return on invested capital (ROIC) is 9.27%.
| Return on Equity (ROE) | 3.35% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 9.27% |
| Return on Capital Employed (ROCE) | 4.06% |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | 1.39M |
| Profits Per Employee | 139,605 |
| Employee Count | 312 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 3.14 |
Taxes
In the past 12 months, SHA:688247 has paid 4.88 million in taxes.
| Income Tax | 4.88M |
| Effective Tax Rate | 10.07% |
Stock Price Statistics
The stock price has decreased by -8.67% in the last 52 weeks. The beta is 0.15, so SHA:688247's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -8.67% |
| 50-Day Moving Average | 9.45 |
| 200-Day Moving Average | 10.48 |
| Relative Strength Index (RSI) | 38.22 |
| Average Volume (20 Days) | 2,125,335 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688247 had revenue of CNY 432.19 million and earned 43.56 million in profits. Earnings per share was 0.10.
| Revenue | 432.19M |
| Gross Profit | 169.39M |
| Operating Income | 55.47M |
| Pretax Income | 48.43M |
| Net Income | 43.56M |
| EBITDA | 90.69M |
| EBIT | 55.47M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 777.34 million in cash and 6,593 in debt, with a net cash position of 777.33 million or 1.73 per share.
| Cash & Cash Equivalents | 777.34M |
| Total Debt | 6,593 |
| Net Cash | 777.33M |
| Net Cash Per Share | 1.73 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 3.16 |
| Working Capital | 868.33M |
Cash Flow
In the last 12 months, operating cash flow was 69.92 million and capital expenditures -31.34 million, giving a free cash flow of 38.58 million.
| Operating Cash Flow | 69.92M |
| Capital Expenditures | -31.34M |
| Depreciation & Amortization | 35.21M |
| Net Borrowing | n/a |
| Free Cash Flow | 38.58M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 39.19%, with operating and profit margins of 12.84% and 10.08%.
| Gross Margin | 39.19% |
| Operating Margin | 12.84% |
| Pretax Margin | 11.21% |
| Profit Margin | 10.08% |
| EBITDA Margin | 20.98% |
| EBIT Margin | 12.84% |
| FCF Margin | 8.93% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | -6.06% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 63.91% |
| Buyback Yield | 2.55% |
| Shareholder Yield | 3.09% |
| Earnings Yield | 1.08% |
| FCF Yield | 0.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |